Due to the automated mes system there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, visual and functional testing as well as physical analysis cannot be performed.The reported event is covered in the device dfu.As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The product was not returned for the analysis and the reported defects could not be confirmed.No anomalies were noted to the device prior to the procedure and the dfu was followed during the preparation of the device.As per the event description, 'the physician reported the fact that: physician had manipulated and resheathed the stent more than 3 times, especially with 2 pipelines in place.During mid deployment the resheathing pad fell off the device, however physician had the cat 5 distal enough to deploy the stent safely.Managed to deploy the stent safely.However, the resheathing pad fell off from the device while deploying'.While the dfu states "caution: do not attempt to partially deploy and recapture the implant more than three times or a loss of resheath performance may occur" it is most probable that the anatomical factors present during the clinical procedure contributed to the fact the device was resheath more than 3 times and therefore to the subsequent fracture and resheathing issue.An assignable cause of procedural factors will be assigned to the reported event, as the issue is associated with a product that meets design and manufacture specifications and was used in according with the dfu but due to procedural and/or anatomical factors during use, the product performance was limited.
|